NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development Program at Benzinga Healthcare Small Cap Conference
/PRNewswire/ -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel...
United States Nanoviricides Inc Drug Administration Exchange Commission Committee For Medicinal Products Human Development To Enter Clinical Trials
Source: prnewswire.com